Tuberculosis inflicts damage far beyond the lungs. While the disease is best known as a respiratory infection, the bacterium *Mycobacterium tuberculosis* can attack the brain, spine, kidneys, heart, and lymph nodes, and the consequences of even a successfully treated case often linger for years. Roughly a quarter of the global population carries the infection in a dormant state, and when it activates, the body’s own immune response becomes a major driver of tissue destruction.
How the Bacteria Settle In
Once inhaled, *M. tuberculosis* makes its home inside the very immune cells sent to destroy it. The bacterium targets macrophages and blocks the normal self-destruct signals those cells use to eliminate threats. 1Europe PMC / International Journal of Molecular Sciences. The Immune Escape Mechanisms of Mycobacterium Tuberculosis By surviving inside macrophages, the bacteria essentially hijack the body’s first line of defense. The immune system responds by walling off infected cells in a structure called a granuloma, a tightly organized cluster of macrophages and other specialized cells surrounded by a ring of lymphocytes.2PubMed Central. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?
The granuloma is often described as a standoff. When it works well, it contains the infection indefinitely, which is what happens in latent TB. When it fails, the center of the granuloma dies in a process called caseation, a cheese-like breakdown of tissue that releases bacteria into surrounding areas. This failure can be triggered by too much or too little of the inflammatory signal TNF, by inadequate clearing of infected dead cells, or by shifts in immune cell response.3Frontiers in Immunology. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals – Section: What causes necrosis and caseation of TB granulomas? The immune system’s delicate balancing act determines whether a person stays latently infected for decades or develops active, destructive disease.
Lung Destruction and Cavitation
The hallmark of pulmonary TB is the cavity, a hole carved into lung tissue where functional tissue has been replaced by dead, hollowed-out space. These cavities are not simply eaten away by the bacteria themselves. Instead, the body’s inflammatory response drives the production of enzymes called matrix metalloproteinases (MMPs) that chew through the structural proteins holding lung tissue together. In TB, these enzymes are released from immune cells and tissue lining cells in quantities that overwhelm the body’s natural inhibitors, tipping the balance toward unchecked tissue destruction.4PubMed Central. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases
Research comparing cavitary lesions to non-cavitary granulomas has found that one particular enzyme, MMP-1, is produced at significantly higher levels in areas progressing toward cavitation, while the protein that normally keeps it in check drops sharply at the cavity surface.5PubMed Central. Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation This is what makes TB so destructive compared to many other infections: the damage comes largely from the host, not the pathogen. Cavities also become ideal breeding grounds for bacteria, creating a vicious cycle in which more bacteria provoke more inflammation and more tissue loss.
When TB Leaves the Lungs
About one in five TB cases involves sites outside the lungs, a category known as extrapulmonary TB. The bacterium spreads through the bloodstream or lymphatic system, and because it can survive inside immune cells, it can seed infections in organs throughout the body. The range of organs affected is surprisingly broad.
Lymph Nodes
The most common form of extrapulmonary TB is lymph node infection, particularly in the neck. Known historically as scrofula, cervical tuberculous lymphadenitis presents as one or more slowly enlarging neck masses that can be difficult to distinguish from lymphoma or other conditions.6PubMed Central. Cervical Tuberculous Lymphadenitis Associated With New-Onset Acanthosis Nigricans Following Antitubercular Therapy: A Case Report Cervical lymph nodes account for roughly 60 to 90 percent of all tuberculous lymph node cases.7International Journal of Mycobacteriology. A Classic Case of Scrofula-cervical Tuberculous Lymphadenitis – Section: Discussion The swollen nodes can mat together, form abscesses, and drain through the skin if untreated.
Brain and Spinal Cord
Tuberculous meningitis is the most feared extrapulmonary form, representing a medical emergency with high rates of death and lasting disability.8PubMed Central. The pathogenesis of tuberculous meningitis The bacteria breach the protective barriers around the brain, triggering an intense inflammatory response that can injure brain tissue directly. In children, this inflammation has been linked to a process called neuronal excitotoxicity, in which nerve cells become damaged from overstimulation by chemical messengers.9Nature Communications. Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity – Section: Results Survivors frequently deal with cognitive problems, hearing loss, or paralysis.
Spinal TB, sometimes called Pott’s disease, attacks the vertebral bodies and the discs between them. The infection eats away at the front of the vertebrae, causing them to collapse and wedge forward, which can produce a visible hunchback deformity known as kyphosis.10PubMed Central. Spinal tuberculosis: a review If the collapse compresses the spinal cord, neurological problems including weakness or paralysis of the legs may follow. Surgery is reserved for cases with significant deformity or nerve damage.11PubMed Central. Tuberculosis of the spine
Heart
TB can infect the pericardium, the sac surrounding the heart. Pericardial TB is relatively common in areas where the disease is endemic, especially in people with HIV, and TB is the leading cause of constrictive pericarditis in those regions.12PubMed Central. Tuberculosis and the Heart Constrictive pericarditis happens when inflammation thickens and scars the pericardium so severely that it squeezes the heart, limiting its ability to fill and pump blood. Whether anti-inflammatory steroids prevent this progression remains uncertain, and surgical removal of the pericardium is often the only effective treatment once constriction sets in.13PubMed. Tuberculous pericarditis Rarer cardiac complications include direct infection of the heart muscle and inflammation of the coronary arteries or aorta.14PubMed Central. Tuberculosis and Cardiovascular Complications: An Overview
Kidneys and Urinary Tract
Urogenital TB makes up about 27 percent of extrapulmonary cases.15PubMed Central. Renal tuberculosis in the modern era The kidneys are seeded by blood-borne bacteria, sometimes years after the original lung infection. Symptoms tend to be vague and slow to develop, which frequently delays the diagnosis long enough for the kidney to be permanently damaged. Because the bacteria arrive through the bloodstream, there is a real risk that both kidneys become involved.16PubMed Central. Tuberculosis of the genitourinary system-Urinary tract tuberculosis: Renal tuberculosis-Part I
Miliary TB
When immune defenses fail broadly, massive numbers of bacteria spill into the bloodstream and seed tiny lesions throughout the body. This is miliary TB, named for the millet-seed-sized tubercles visible on imaging and at autopsy.17PubMed Central. Miliary Tuberculosis Miliary TB can hit the liver, spleen, bone marrow, eyes, and adrenal glands simultaneously. It is one of the most dangerous forms of the disease and tends to occur in people whose immune systems are severely weakened.
Long-Term Lung Damage After Treatment
Completing TB treatment and clearing the bacteria does not mean the lungs return to normal. A growing body of evidence describes a condition called post-TB lung disease, or PTLD, in which respiratory symptoms and measurable airflow problems persist long after the infection is gone. In one large population study, people with a history of treated TB reported respiratory symptoms at a much higher rate than those without that history (about 47 percent versus 28 percent), and roughly one in five had airflow obstruction.18PubMed Central. Post-tuberculosis lung disease and chronic obstructive pulmonary disease – Section: Epidemiology of PTLD That pattern resembles chronic obstructive pulmonary disease and can worsen with time.
Cavities left behind by the disease create another risk. Old TB cavities are prone to colonization by the fungus *Aspergillus*, which can form a dense ball of fungal material inside the cavity. This condition, aspergilloma, sometimes causes life-threatening bleeding if the fungal ball erodes into a blood vessel.19PubMed Central. Massive Hemoptysis with a Fungus Ball-like Shadow in an Old Tuberculosis Cavity That Was Shown to Be a Clot by Bronchoscopy 20PubMed Central. Pulmonary Tuberculosis with Concomitant Aspergillus Fungal Ball in a Diabetic Indian Male: A Rare Case Report People who were treated for cavitary TB may need periodic monitoring for new symptoms like coughing up blood, even years later.
Cardiovascular Risk After TB
Beyond direct infection of the heart, there is growing evidence that TB leaves behind a lasting cardiovascular footprint. A cohort study using health records from both the United States and the United Kingdom found that during and shortly after active TB, people had roughly two to three times the usual rate of cardiovascular events compared to matched individuals without TB.21Clinical Infectious Diseases. Tuberculosis and Increased Incidence of Cardiovascular Disease: Cohort Study Using United States and United Kingdom Health Records – Section: RESULTS That heightened risk was not fully explained by differences in baseline cardiovascular health.
A nationwide Korean survey reached a complementary conclusion: TB survivors were substantially more likely to fall into the high-risk category for ten-year cardiovascular disease risk, with an odds ratio of about 1.7 for the high-risk group compared to matched controls.22Frontiers in Cardiovascular Medicine. Tuberculosis survivors and the risk of cardiovascular disease: analysis using a nationwide survey in Korea – Section: Results The mechanisms are not entirely settled, but sustained systemic inflammation during active TB, vascular endothelial damage, and metabolic disruption are all suspected contributors. The practical implication is that cardiovascular screening may be warranted for TB survivors, especially those with other risk factors.
Mental Health and Quality of Life
The toll of TB extends to psychological health. A large nationwide cohort study in South Korea found that TB survivors had about a 20 percent higher risk of developing depression than matched controls, with the association especially pronounced in men, where the risk was roughly 32 percent higher.23Frontiers in Psychiatry. The risk of developing depression in tuberculosis survivors: a nationwide cohort study in South Korea – Section: Results During treatment itself, the picture can be even bleaker. One follow-up study found that nearly a quarter of patients remained at risk of depression even at the end of their TB treatment course, despite improvement in physical symptoms.24PubMed Central. Mental Health Status and Its Impact on TB Treatment and Its Outcomes: A Scoping Literature Review – Section: Discussion
Depression is not simply a response to feeling ill. Months of isolation (TB patients are often kept away from family members to prevent transmission), social stigma, side effects of the drugs, loss of employment, and persistent fatigue all compound the psychological burden. The economic and social dimensions of post-TB wellbeing are recognized as significant problems in their own right.25PubMed Central. Post-TB health and wellbeing
Liver Injury From Treatment
The standard drugs used to treat TB, particularly isoniazid, rifampicin, and pyrazinamide, are themselves hard on the body. The liver bears the brunt. Drug-induced liver injury (DILI) is one of the most common serious side effects of anti-TB therapy. In one large cohort, about 4 percent of patients developed clinically significant liver damage during treatment.26PubMed Central. Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients – Section: Results That rate can climb much higher in certain groups: patients who also carry hepatitis B had liver toxicity rates around 59 percent in one study, compared to 24 percent in those without the virus.27PubMed Central. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus – Section: Results
Liver injury during treatment can range from a mild, temporary bump in liver enzymes to severe hepatitis requiring a change in the drug regimen. In serious cases, treatment has to be paused or switched to less effective but less toxic alternatives, which lengthens the overall course and can give the bacteria time to develop resistance. Among patients who developed DILI in one retrospective study, a large majority had high-grade injury.28PubMed Central. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study – Section: Results This is one reason clinicians monitor liver function throughout therapy, especially in patients with pre-existing liver conditions, heavy alcohol use, or viral hepatitis.
How HIV and Diabetes Amplify the Damage
Two conditions dramatically worsen what TB does to the body. HIV attacks the same immune cells, CD4+ T lymphocytes, that are critical for forming and maintaining the granulomas that contain TB. Research has shown that HIV infection leads to poorly formed granulomas, and the lower a person’s CD4+ count drops, the less structurally intact those granulomas become.29PubMed Central. HIV-MTB Co-Infection Reduces CD4+ T Cells and Affects Granuloma Integrity When containment breaks down, TB spreads more widely, the disease progresses faster, and the risk of miliary or extrapulmonary disease rises sharply.
Diabetes creates a different but equally damaging dynamic. People with diabetes who develop TB tend to have more severe clinical disease, including a higher likelihood of lung cavities, slower clearing of bacteria from the sputum, and a roughly threefold higher chance of treatment failure.30PubMed Central. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes – Section: RESULTS High blood sugar is thought to fuel more inflammatory lung damage and promote cavity formation.31Frontiers in Cellular and Infection Microbiology. The cause–effect relation of tuberculosis on incidence of diabetes mellitus – Section: 3 Impact of diabetes on the susceptibility to tuberculosis The relationship also runs in the opposite direction: TB itself can worsen blood sugar control, making management of both diseases harder simultaneously.
TB in Children, Older Adults, and Pregnancy
TB does not behave the same way in everyone. Infants and young children are more likely than adults to develop life-threatening forms of the disease, including miliary TB and tuberculous meningitis, because their immune systems have not yet matured enough to wall off the infection effectively.32PubMed Central. Tuberculosis in children Diagnosis in children is also more difficult because the clinical and imaging signs are less specific than in adults.
In older adults, the primary concern is reactivation. Most elderly TB cases arise not from new exposure but from latent infections acquired decades earlier. As the immune system naturally weakens with age, the granulomas that have been holding dormant bacteria in check can begin to fail, allowing the bacteria to multiply again.33PubMed Central. Tuberculosis in the Elderly Modeling of immune dynamics suggests that declining production of CD4+ T cells with age gradually undermines the equilibrium that keeps latent infection in check, sometimes after many decades of containment.34PLOS ONE. The Roles of Immune Memory and Aging in Protective Immunity and Endogenous Reactivation of Tuberculosis – Section: Results
During pregnancy, TB poses risks to both mother and baby. A systematic review and meta-analysis found that pregnant women with active TB had nearly three times the odds of maternal complications, nearly four times the odds of anemia, and significantly higher rates of preterm birth and low birth weight compared to pregnant women without TB.35PubMed. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis – Section: MAIN RESULTS Additional complications can include gestational hypertension, postpartum hemorrhage, and sepsis, while the fetus faces increased risks of growth restriction, stillbirth, and, in rare cases, congenital TB transmitted from the mother.36Frontiers in Cellular and Infection Microbiology. Adverse pregnancy outcomes and complications of tuberculosis in pregnant women Timely diagnosis and treatment dramatically improve outcomes for both mother and child.37PubMed Central. Tuberculosis in Pregnancy
An Ancient Coevolution
The scope of TB’s effects on the human body reflects an extraordinarily long shared history. Skeletal evidence of tuberculosis dates back to the Neolithic period, with characteristic bone lesions found in ancient remains from Europe, Egypt, and pre-Columbian America.38PubMed Central. The paleopathological evidence on the origins of human tuberculosis: a review These recognizable bone changes occur in only about 5 percent of untreated infections, meaning the archaeological record captures just a fraction of what was likely a far more widespread disease even thousands of years ago.39PubMed. Paleomicrobiology of Human Tuberculosis
This millennia-long coevolution helps explain why the bacterium is so adept at manipulating human immunity. *M. tuberculosis* does not produce a potent toxin or multiply explosively the way some pathogens do. Instead, it plays a slow, strategic game, hiding inside immune cells, modulating inflammatory signals, and exploiting any weakening of immune surveillance. The result is a disease capable of remaining silent for an entire lifetime in some people while producing catastrophic, multi-organ damage in others. That range is the signature of a pathogen that has had thousands of human generations in which to refine its survival tactics.